Invesaro

Stocks SPNT Financial statements

Financial statements

SiriusPoint Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SiriusPoint Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue6899393709838902,1812,1062,7372,6043,205
General and administrative39.453.136.253.861.4
Interest expense8.238.238.238.28.23438.664.169.679.7
Pre-tax income34.5294-32120115245.1-423319233541
Income tax5.5912-4.010.78.1-10.7-36.7-4530.781.2
Net income to minority interests1.243.970.2200.3-2.30.88.92.50.5
Net income27.6278-31820114458.1-387355200460
EPS, basic0.262.71-3.272.181.540.28-2.511.931.063.80
EPS, diluted0.262.64-3.272.161.530.27-2.511.851.043.64
Shares, basic (weighted)10410297.191.892.5149160163167117
Shares, diluted (weighted)10610597.192.793150160170169122

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents9.958.21046395261,000705969682731
Lease right-of-use assets0.827.425.925.622.820.7
Goodwill0
Intangible assets0172164153141121
Total assets3,8964,6723,0863,4403,53510,61811,03612,87212,52512,570
Total liabilities2,4462,9021,8822,0261,9708,1158,95410,34110,58610,099
Total debt114817778786639689
Paid-in capital1,0951,1009199289341,6231,6411,693945968
Retained earnings3165942764776206652626017851,229
Treasury stock-7.39-48.30
Other comprehensive income0-0.2-453.1-4.161.9
Shareholders' equity1,4141,6561,2051,4141,5642,5042,0752,5141,9372,470
Minority interests35.75.41001.4-0.47.916.71.41.1
Total equity1,4501,6611,2051,4141,5652,5032,0832,5311,9392,471
Total liabilities and equity3,8964,6723,0863,4403,53510,61811,03612,87212,52512,570
Shares outstanding10610393.694.295.6162162168116117

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income28.9282-31720114455.8-386364202460
Stock-based compensation8.943.64.9676.611.430.521.420.735.9
Deferred income tax-1.239.15-100.68-34.2-39.2-77.310.933
Change in payables-2.124.2-24.710.6-3.3-25.536.811.5-8.9
Cash from operations4.77-78.513.414173.31.629358174.7102
Purchases of investments-331-431-3,410-6,161-4,966-2,271-2,254
Sales and maturities of investments4465322,6884,1114,591
Cash from investing-85.32653787876209-1,304-332344424
Debt issued00
Debt repaid00-5180
Stock issued5.141.5101.9050.80018.40.9
Share buybacks-7.4-40.9-139000-50-300-491
Dividends paid000000
Cash from financing38.153.7-22712.6-19.424.3-23.7-61.5-625-519
Net change in cash-42.424016494159.9235-1,035188-2077.8
Interest paid2321.425.68.18.339.339.246.166.478
Income taxes paid5.957.817.2700.114.7-2.249.650.681.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $25.38 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Pre-tax margin18.4%Pre-tax income / revenue.
Net margin15.6%Net income / revenue.
Operating cash flow margin8.2%Cash from operations / revenue.
Effective tax rate15.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)22.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)4.0%Net income / average total assets.
Stock-based pay / revenue1.2%Stock-based compensation (from the cash flow statement) / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y23.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y15.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y29.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y129.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y26.2%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y250.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y18.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y37.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-29.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y6.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y27.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y9.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y0.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y28.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-28.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-8.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y5.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Debt / equity0.30xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets5.3%Total debt / total assets.
Liabilities / assets82.0%Total liabilities / total assets.
Net debt$60.7MTotal debt - cash - short-term investments. Negative means more cash than debt.
Goodwill and intangibles / assets1.2%(Goodwill + intangible assets) / total assets.
Tangible book value$2.12BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.26xRevenue / average total assets.

Per share

MetricValueHow it is calculated
EPS, diluted$4.25Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$27.29Revenue / diluted weighted shares.
Operating cash flow per share$2.23Cash from operations / diluted weighted shares.
Book value per share$19.61Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$18.26Tangible book value / shares outstanding.
Cash per share$5.30(Cash + short-term investments) / shares outstanding.
Payout ratio0.0%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$2.95BShare price x shares outstanding.
Enterprise value$3.01BMarket cap + total debt - cash - short-term investments.
P/E5.83xMarket cap / net income. Only when net income is positive.
P/S0.91xMarket cap / revenue.
P/B1.30xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.39xMarket cap / tangible book value, when positive.
P/OCF11.1xMarket cap / cash from operations, when positive.
EV/Sales0.93xEnterprise value / revenue.
Earnings yield17.1%Net income / market cap (the inverse of P/E).
Dividend yield0.0%Dividends paid over the period / market cap.
Shareholder yield2.5%(Dividends paid + share buybacks) / market cap.
What was SiriusPoint Ltd's revenue in fiscal 2025?

SiriusPoint Ltd reported revenue of $3.21B for fiscal 2025, 23.1% higher than the year before.

Was SiriusPoint Ltd profitable in fiscal 2025?

Yes. Net income was $459.6M, a net margin of 14.3%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SiriusPoint Ltd